Teijin Ltd (3401) - Financial and Strategic SWOT Analysis Review
Teijin Ltd (3401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Teijin Ltd (Teijin) is a technology driven holding company that offers solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It manufactures and sells aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products, pharmaceuticals, medical devices and water purification systems. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, and other diseases. It also offers home oxygen therapy devices and sleep disordered breathing related devices, among others. Teijin operates facilities in America, Europe, Asia and Japan. The company sells its products in Asia, the Americas and Europe. Teijin is headquartered in Tokyo, Japan.
Teijin Ltd Key Recent Developments
Jan 31,2020: Teijin: Notice regarding change in representative directors
Jan 15,2020: Teijin Home Healthcare to change its Name
May 14,2019: Teijin and AMED sign R&D consignment agreement to develop drugs for Frail
Feb 04,2019: Teijin: Consolidated financial statements summary for the the nine months ended December 31, 2018
Feb 04,2019: Teijin Limited has made the following personnel changes effective as of June 20, 2019
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Teijin Ltd (Teijin) is a technology driven holding company that offers solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It manufactures and sells aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products, pharmaceuticals, medical devices and water purification systems. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, and other diseases. It also offers home oxygen therapy devices and sleep disordered breathing related devices, among others. Teijin operates facilities in America, Europe, Asia and Japan. The company sells its products in Asia, the Americas and Europe. Teijin is headquartered in Tokyo, Japan.
Teijin Ltd Key Recent Developments
Jan 31,2020: Teijin: Notice regarding change in representative directors
Jan 15,2020: Teijin Home Healthcare to change its Name
May 14,2019: Teijin and AMED sign R&D consignment agreement to develop drugs for Frail
Feb 04,2019: Teijin: Consolidated financial statements summary for the the nine months ended December 31, 2018
Feb 04,2019: Teijin Limited has made the following personnel changes effective as of June 20, 2019
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Teijin Ltd - Key Facts
Teijin Ltd - Key Employees
Teijin Ltd - Key Employee Biographies
Teijin Ltd - Major Products and Services
Teijin Ltd - History
Teijin Ltd - Company Statement
Teijin Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Teijin Ltd - Business Description
Business Segment: Healthcare
Overview
Performance
Business Segment: Materials
Overview
Performance
Business Segment: Others
Overview
Performance
Geographical Segment: Americas (excluding the US)
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe and Others
Performance
Geographical Segment: Japan
Performance
Geographical Segment: PRC
Performance
Geographical Segment: The US
Performance
R&D Overview
Teijin Ltd - Corporate Strategy
Teijin Ltd - SWOT Analysis
SWOT Analysis - Overview
Teijin Ltd - Strengths
Teijin Ltd - Weaknesses
Teijin Ltd - Opportunities
Teijin Ltd - Threats
Teijin Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Teijin Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 31, 2020: Teijin: Notice regarding change in representative directors
Jan 15, 2020: Teijin Home Healthcare to change its Name
May 14, 2019: Teijin and AMED sign R&D consignment agreement to develop drugs for Frail
Feb 04, 2019: Teijin: Consolidated financial statements summary for the the nine months ended December 31, 2018
Feb 04, 2019: Teijin Limited has made the following personnel changes effective as of June 20, 2019
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Teijin Ltd - Key Facts
Teijin Ltd - Key Employees
Teijin Ltd - Key Employee Biographies
Teijin Ltd - Major Products and Services
Teijin Ltd - History
Teijin Ltd - Company Statement
Teijin Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Teijin Ltd - Business Description
Business Segment: Healthcare
Overview
Performance
Business Segment: Materials
Overview
Performance
Business Segment: Others
Overview
Performance
Geographical Segment: Americas (excluding the US)
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe and Others
Performance
Geographical Segment: Japan
Performance
Geographical Segment: PRC
Performance
Geographical Segment: The US
Performance
R&D Overview
Teijin Ltd - Corporate Strategy
Teijin Ltd - SWOT Analysis
SWOT Analysis - Overview
Teijin Ltd - Strengths
Teijin Ltd - Weaknesses
Teijin Ltd - Opportunities
Teijin Ltd - Threats
Teijin Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Teijin Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 31, 2020: Teijin: Notice regarding change in representative directors
Jan 15, 2020: Teijin Home Healthcare to change its Name
May 14, 2019: Teijin and AMED sign R&D consignment agreement to develop drugs for Frail
Feb 04, 2019: Teijin: Consolidated financial statements summary for the the nine months ended December 31, 2018
Feb 04, 2019: Teijin Limited has made the following personnel changes effective as of June 20, 2019
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Teijin Ltd, Key Facts
Teijin Ltd, Key Employees
Teijin Ltd, Key Employee Biographies
Teijin Ltd, Major Products and Services
Teijin Ltd, History
Teijin Ltd, Other Locations
Teijin Ltd, Subsidiaries
Teijin Ltd, Key Competitors
Teijin Ltd, Ratios based on current share price
Teijin Ltd, Annual Ratios
Teijin Ltd, Annual Ratios (Cont...1)
Teijin Ltd, Annual Ratios (Cont...2)
Teijin Ltd, Interim Ratios
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Teijin Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Teijin Ltd, Key Facts
Teijin Ltd, Key Employees
Teijin Ltd, Key Employee Biographies
Teijin Ltd, Major Products and Services
Teijin Ltd, History
Teijin Ltd, Other Locations
Teijin Ltd, Subsidiaries
Teijin Ltd, Key Competitors
Teijin Ltd, Ratios based on current share price
Teijin Ltd, Annual Ratios
Teijin Ltd, Annual Ratios (Cont...1)
Teijin Ltd, Annual Ratios (Cont...2)
Teijin Ltd, Interim Ratios
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Teijin Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Teijin Ltd, Performance Chart (2016 - 2020)
Teijin Ltd, Ratio Charts
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teijin Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
The Dow Chemical Co
Takeda Pharmaceutical Co Ltd
Sumitomo Chemical Co Ltd
Nippon Chemical Industrial Co Ltd
Mitsubishi Chemical Corp
Kaneka Corp
Hyosung Corp
Hamamatsu Photonics KK
Daiichi Sankyo Co Ltd
Celanese Corp
Teijin Ltd, Performance Chart (2016 - 2020)
Teijin Ltd, Ratio Charts
Teijin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teijin Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
The Dow Chemical Co
Takeda Pharmaceutical Co Ltd
Sumitomo Chemical Co Ltd
Nippon Chemical Industrial Co Ltd
Mitsubishi Chemical Corp
Kaneka Corp
Hyosung Corp
Hamamatsu Photonics KK
Daiichi Sankyo Co Ltd
Celanese Corp